These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hypertension: treating the patient as well as the blood pressure. Jackson G Int J Clin Pract; 2003 Jun; 57(5):357. PubMed ID: 12846335 [No Abstract] [Full Text] [Related]
7. [Treating essential hypertension. Are beta blockers still first choice?]. Rahn KH MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414 [No Abstract] [Full Text] [Related]
8. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? Grover SA; Coupal L; Zowall H Hypertension; 2005 Jan; 45(1):92-7. PubMed ID: 15545508 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis. Zhang Y; Sun N; Jiang X; Xi Y J Am Soc Hypertens; 2017 Jul; 11(7):394-401. PubMed ID: 28760243 [TBL] [Abstract][Full Text] [Related]
10. Primary and secondary prevention of stroke by antihypertensive drug treatment. Wang JG; Li Y Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529 [TBL] [Abstract][Full Text] [Related]
11. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades. Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553 [TBL] [Abstract][Full Text] [Related]
12. Management of hypertension in patients with enhanced cardiovascular risk. Introduction. White WB Am J Med; 2008 Aug; 121(8 Suppl):S1. PubMed ID: 18638613 [No Abstract] [Full Text] [Related]
13. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653 [TBL] [Abstract][Full Text] [Related]
14. ["Under pressure" -- the clinical relevance of hypertension for the heart and circulation]. Lüscher TF Herz; 2006 Jun; 31(4):285-6. PubMed ID: 16810467 [No Abstract] [Full Text] [Related]
15. Workshop II--Hypertension trials and meta-analyses: is there any value for further studies? Grimm RH; Black H Am J Med; 1991 Feb; 90(2A):24S-25S. PubMed ID: 1825263 [No Abstract] [Full Text] [Related]
16. Control of blood pressure after stroke. Bath PM; Sprigg N Hypertension; 2006 Aug; 48(2):203-4. PubMed ID: 16785329 [No Abstract] [Full Text] [Related]
17. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events. Chrysant SG; Chrysant GS Am J Cardiol; 2010 Sep; 106(6):825-9. PubMed ID: 20816123 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and future cardiovascular risk of patients with not-at-goal hypertension in general practice in France: the AVANT'AGE study. Zhang Y; Lelong H; Kretz S; Agnoletti D; Mourad JJ; Safar ME; Blacher J J Clin Hypertens (Greenwich); 2013 Apr; 15(4):291-5. PubMed ID: 23551730 [TBL] [Abstract][Full Text] [Related]
19. [ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs]. Kuwajima I Nihon Rinsho; 2004 Mar; 62 Suppl 3():648-53. PubMed ID: 15171450 [No Abstract] [Full Text] [Related]
20. [Blood pressure control in chronic stroke]. Nagai M; Hoshide S; Kario K Nihon Rinsho; 2006 Aug; 64 Suppl 6():378-83. PubMed ID: 16981568 [No Abstract] [Full Text] [Related] [Next] [New Search]